Navigation Links
Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007

MINNEAPOLIS, May 23, 2007 (BUSINESS WIRE) -- MGI PHARMA, INC. (NASDAQ:MOGN), a biopharmaceutical company focused in oncology and acute care, today announced the presentation of results of a successful pivotal phase 3 trial of Aquavan(R) (fospropofol disodium) Injection in patients undergoing colonoscopy. Primary and secondary efficacy endpoint results, as well as safety data, were presented at Digestive Disease Week 2007 in Washington, D.C. by Lawrence B. Cohen, MD, Department of Medicine/ Gastroenterology, Mount Sinai School of Medicine, New York.

Aquavan Injection is a proprietary water-soluble prodrug of propofol that is in clinical development for moderate sedation of patients undergoing therapeutic and diagnostic procedures. Aquavan has not yet been approved for marketing by the U.S. Food and Drug Administration (U.S. FDA) or any other regulatory agencies.

"Aquavan has a favorable pharmacokinetic profile, making it possible to deliver a predictable concentration of sedative and achieve the desired level of sedation," said Dr. Cohen, a lead investigator of the trial.

Colonoscopy Results: Primary Endpoint of Sedation Success Achieved (Abstract W1451)

A randomized, double-blind, multi-center phase 3 pivotal trial was conducted to evaluate whether an Aquavan dosing regimen of 6.5 mg/kg would be safe and effective in providing moderate sedation in patients undergoing colonoscopy, compared to a 2.0 mg/kg Aquavan regimen. A total of 312 patients in 18 sites were pre-treated with fentanyl citrate (50 (mu)g) and then received either Aquavan 2.0 mg/kg, Aquavan 6.5 mg/kg or midazolam 0.02 mg/kg (2:3:1 ratio). Gastroenterologists administered the sedatives, as is consistent with a large percentage of routine colonoscopies. Patients were ages 18 and older and in varying states of health and sedation risk.

The results showed that 87% of patients who received an initial bolus dose
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study of Aquavan Injection in Patients Undergoing Bronchoscopy
2. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
3. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
4. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
5. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
6. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
7. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
8. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
9. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
10. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
11. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
Post Your Comments:
(Date:5/29/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/p37spr/north_america ) has announced ... MRI Market - Growth, Trends And Forecasts (2014 - ... key players in the industry are GE , Hitachi ... Medical Systems MRI is a ... its higher sensitivity and use of non-ionizing radiations. Open ...
(Date:5/29/2015)... CAMBRIDGE, Massachusetts and SPARTANBURG, South ... The Guardian Research Network and Molecular Health have ... access and molecular diagnostic decision support to the majority ... The Guardian Research Network will collaborate with Molecular Health ... molecular testing to identify cohorts from hundreds of thousands ...
(Date:5/29/2015)... , May 29, 2015  Haemonetics Corporation (NYSE: ... , Chief Operating Officer, will present at the JMP ... on June 23 rd , 2015 at ... access Mr. Davies, presentation live via webcast at: ... (NYSE: HAE ) is a global healthcare company ...
Breaking Medicine Technology:North America Open System MRI Market 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare and Toshiba Medical Dominating 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4
... Pa., Aug. 22, 2011 Cephalon, Inc. (Nasdaq: ... of its 2.50 percent Convertible Senior Subordinated Notes due ... Subordinated Notes due 2015 (the "2015 Notes") in respect ... with a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd., ...
... Aug. 22, 2011 Clinigene International Limited, ... Phase I-IV Clinical Research Organization, and Spaulding ... Cardiac Core Lab, and Medical Device Manufacturer, ... establishes a reliable, trustworthy, and cost-efficient global ...
Cached Medicine Technology:Cephalon Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes due 2015 2Cephalon Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes due 2015 3Cephalon Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes due 2015 4Cephalon Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes due 2015 5Spaulding Clinical Announces Strategic Partnership with Clinigene International, India for Providing Comprehensive Early Clinical Solutions to Pharmaceutical and Biotech Clients 2Spaulding Clinical Announces Strategic Partnership with Clinigene International, India for Providing Comprehensive Early Clinical Solutions to Pharmaceutical and Biotech Clients 3
(Date:5/29/2015)... 30, 2015 “In the current ... and federal regulations, we provide education that will ... who are suffering from pain, within the boundaries ... MD, professor of rehabilitation medicine and President/Medical Director ... Park, Kansas. , A new flight of PAINWeekEnd ...
(Date:5/29/2015)... CO (PRWEB) May 29, 2015 What ... from The Denver Foundation, community comes together to plant ... to build neighborhoods and awareness of critical issues. Community ... Metro Denver and beyond. , "What Community Does" was ... community foundation in Colorado, and released during the foundation’s ...
(Date:5/29/2015)... 29, 2015 The third annual Newport ... now closed to new registration, starts outside the east ... exciting competitive running event demonstrates the power of combining ... public benefit – in this case, historic preservation. ... the famed Ocean Drive and passes by many Bellevue ...
(Date:5/29/2015)... 29, 2015 The Recovery Village ... abuse, and co-occurring mental health treatment facility, will ... for the general public on June 1st, and ... Recovery Village at Palmer Lake will offer affordable ... utilizing traditional and evidence-based therapies, in a luxurious ...
(Date:5/29/2015)... According to a recent HealthDay article, a government ... a substance abuse problem - the data, which was gathered ... full-time jobs, revealed that 9.5% of those workers had an ... National Council on Alcoholism and Drug Dependence (NCAAD) reports drug ... 70% of the 14.8 million illicit drug users in America ...
Breaking Medicine News(10 mins):Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:What Community Does: A New Video from The Denver Foundation 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 3Health News:Advanced Recovery Systems Announces the Opening of The Recovery Village at Palmer Lake 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 3Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 4
... Hall of Fame inductees Jackson Browne and Graham Nash ... biggest problem: the health of our peopleWASHINGTON, Jan. 6 ... The Vineeta Foundation, a health and human rights organization, ... the Health for All Blue Diamond Ball will be ...
... FASgen, Inc. is pleased to announce that it has ... Inc. This agreement will give Centocor, Inc. and ... the opportunity to discover and develop novel small molecule ... selective inhibition of Fatty Acid Synthase (FAS) for ...
... 6 Nanotechnology can be described as,the ... changing the way many,industries think of surface ... boat hull, a self-cleaning aircraft or a ... commercial reality using nanotechnology,materials and concepts. Nanovere ...
... Heine and Riester, giving physicians and researchers a one-stop online shop ... ... (Vocus) January 6, 2009 -- ORSupply.com, the largest online marketplace for ... unveiling a new range of otoscopes from Welch Allyn, Heine, and ...
... of member self-scheduling via the Internet , ... ... the industry leader in online customer self-scheduling software, announced several ... base. Major program providers such as Lifecare, Inc., which ...
... Jan. 6 Dr. Siegal,s Direct Nutritionals, ... ) and,worldwide distributor of the internationally-popular Dr. ... products, today announced,that renowned physician, author, and ... attend a grand opening event at the ...
Cached Medicine News:Health News:Health for All Blue Diamond Ball Scheduled to Celebrate Obama's Inauguration 2Health News:FASgen, Inc. Announces Research and License Agreement With Centocor, Inc. 2Health News:Nanotechnology Causes Disruption - Cross Industry 2Health News:ORSupply.com Unveils Largest Selection of Otoscopes Available Anywhere 2Health News:ORSupply.com Unveils Largest Selection of Otoscopes Available Anywhere 3Health News:Online Scheduling Software Is Revolutionizing the Wellness Industry 2Health News:Dr. Sanford Siegal and Weight Loss Success Story Josie Raper, Who Appears on Current People Magazine Cover, to Attend Grand Opening of Dr. Siegal's COOKIE DIET Store in Beverly Hills 2
... MOBEE headboxes are ... Xltek's line of portable ... with a robust new ... latest software, XLTEK's standard ...
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
... The ACCU-Beam® line of Surgical Microscope Accessories ... lenses, fiber optic cables, and fiberoptic retrofits. ... (US pat. no. 5,264,928) is the only ... 3CCD cameras on the same adaptor body. ...
Medicine Products: